A citation-based method for searching scientific literature

Yoshihiro Miyake, Keiko Tanaka, Wakaba Fukushima, Satoshi Sasaki, Chikako Kiyohara, Yoshio Tsuboi, Tatsuo Yamada, Tomoko Oeda, Takami Miki, Nobutoshi Kawamura, Nobutaka Sakae, Hidenao Fukuyama, Yoshio Hirota, Masaki Nagai. J Neurol Sci 2010
Times Cited: 87







List of co-cited articles
828 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.
Kelly Claire Simon, Honglei Chen, Michael Schwarzschild, Alberto Ascherio. Neurology 2007
165
48

Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study.
Giulio Scigliano, Massimo Musicco, Paola Soliveri, Immacolata Piccolo, Gabriele Ronchetti, Floriano Girotti. Stroke 2006
142
40

Type 2 diabetes and the risk of Parkinson's disease.
Gang Hu, Pekka Jousilahti, Siamak Bidel, Riitta Antikainen, Jaakko Tuomilehto. Diabetes Care 2007
291
37

Total cholesterol and the risk of Parkinson disease.
G Hu, R Antikainen, P Jousilahti, M Kivipelto, J Tuomilehto. Neurology 2008
143
33

Low LDL cholesterol and increased risk of Parkinson's disease: prospective results from Honolulu-Asia Aging Study.
Xuemei Huang, Robert D Abbott, Helen Petrovitch, Richard B Mailman, G Webster Ross. Mov Disord 2008
89
29

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.
Xuemei Huang, Honglei Chen, William C Miller, Richard B Mailman, Jennifer L Woodard, Peter C Chen, Dong Xiang, Richard W Murrow, Yi-Zhe Wang, Charles Poole. Mov Disord 2007
140
27

Serum cholesterol levels and the risk of Parkinson's disease.
Lonneke M L de Lau, Peter J Koudstaal, Albert Hofman, Monique M B Breteler. Am J Epidemiol 2006
143
27

Diabetes and risk of Parkinson's disease.
Qun Xu, Yikyung Park, Xuemei Huang, Albert Hollenbeck, Aaron Blair, Arthur Schatzkin, Honglei Chen. Diabetes Care 2011
167
26

Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis.
Emanuele Cereda, Michela Barichella, Carlo Pedrolli, Catherine Klersy, Erica Cassani, Riccardo Caccialanza, Gianni Pezzoli. Diabetes Care 2011
138
26

Diabetes and the risk of developing Parkinson's disease in Denmark.
Eva Schernhammer, Johnni Hansen, Kathrine Rugbjerg, Lene Wermuth, Beate Ritz. Diabetes Care 2011
120
25

Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease.
Jane A Driver, Ashley Smith, Julie E Buring, J Michael Gaziano, Tobias Kurth, Giancarlo Logroscino. Diabetes Care 2008
106
22

Diabetes preceding Parkinson's disease onset. A case-control study.
Marco D'Amelio, Paolo Ragonese, Graziella Callari, Norma Di Benedetto, Barbara Palmeri, Valeria Terruso, Giuseppe Salemi, Giorgia Famoso, Paolo Aridon, Giovanni Savettieri. Parkinsonism Relat Disord 2009
50
38

Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk.
Karen M Powers, Terri Smith-Weller, Gary M Franklin, W T Longstreth, Phillip D Swanson, Harvey Checkoway. Parkinsonism Relat Disord 2006
65
27

Metabolic markers or conditions preceding Parkinson's disease: a case-control study.
Rodolfo Savica, Brandon R Grossardt, J Eric Ahlskog, Walter A Rocca. Mov Disord 2012
33
51

Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.
Xuemei Huang, Alvaro Alonso, Xuguang Guo, David M Umbach, Maya L Lichtenstein, Christie M Ballantyne, Richard B Mailman, Thomas H Mosley, Honglei Chen. Mov Disord 2015
87
19

Obesity, diabetes, and risk of Parkinson's disease.
Natalia Palacios, Xiang Gao, Marjorie L McCullough, Eric J Jacobs, Alpa V Patel, Tinisha Mayo, Michael A Schwarzschild, Alberto Ascherio. Mov Disord 2011
100
18

Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications.
Yu Sun, Ya-Hui Chang, Hua-Fen Chen, Ying-Hwa Su, Hui-Fang Su, Chung-Yi Li. Diabetes Care 2012
125
18

Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study.
Chengxuan Qiu, Gang Hu, Miia Kivipelto, Tiina Laatikainen, Riitta Antikainen, Laura Fratiglioni, Pekka Jousilahti, Jaakko Tuomilehto. Hypertension 2011
94
17

Serum cholesterol and the progression of Parkinson's disease: results from DATATOP.
Xuemei Huang, Peggy Auinger, Shirley Eberly, David Oakes, Michael Schwarzschild, Alberto Ascherio, Richard Mailman, Honglei Chen. PLoS One 2011
43
32

Diabetes in patients with idiopathic Parkinson's disease.
Claudia Becker, Gunnar P Brobert, Saga Johansson, Susan S Jick, Christoph R Meier. Diabetes Care 2008
50
26

Body mass index and the risk of Parkinson disease.
G Hu, P Jousilahti, A Nissinen, R Antikainen, M Kivipelto, J Tuomilehto. Neurology 2006
131
12

Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's disease.
Pazit Bar-On, Leslie Crews, Andrew O Koob, Hideya Mizuno, Anthony Adame, Brian Spencer, Eliezer Masliah. J Neurochem 2008
125
12

Insulin resistance impairs nigrostriatal dopamine function.
J K Morris, G L Bomhoff, B K Gorres, V A Davis, J Kim, P-P Lee, W M Brooks, G A Gerhardt, P C Geiger, J A Stanford. Exp Neurol 2011
93
12

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
407
12

Prospective study of statin use and risk of Parkinson disease.
Xiang Gao, Kelly C Simon, Michael A Schwarzschild, Alberto Ascherio. Arch Neurol 2012
89
12

Exenatide and the treatment of patients with Parkinson's disease.
Iciar Aviles-Olmos, John Dickson, Zinovia Kefalopoulou, Atbin Djamshidian, Peter Ell, Therese Soderlund, Peter Whitton, Richard Wyse, Tom Isaacs, Andrew Lees,[...]. J Clin Invest 2013
286
12

Prospective study on the components of metabolic syndrome and the incidence of Parkinson's disease.
Katri Sääksjärvi, Paul Knekt, Satu Männistö, Jukka Lyytinen, Markku Heliövaara. Parkinsonism Relat Disord 2015
37
29

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Dilan Athauda, Kate Maclagan, Simon S Skene, Martha Bajwa-Joseph, Dawn Letchford, Kashfia Chowdhury, Steve Hibbert, Natalia Budnik, Luca Zampedri, John Dickson,[...]. Lancet 2017
354
12

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study.
E Cereda, M Barichella, E Cassani, R Caccialanza, G Pezzoli. Neurology 2012
92
11

Statin use and the risk of Parkinson disease.
Angelika D Wahner, Jeff M Bronstein, Yvette M Bordelon, Beate Ritz. Neurology 2008
96
11

Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.
Xuejing Yue, Hehua Li, Haiqing Yan, Ping Zhang, Li Chang, Tong Li. Medicine (Baltimore) 2016
80
12

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.
Eduardo De Pablo-Fernandez, Raph Goldacre, Julia Pakpoor, Alastair J Noyce, Thomas T Warner. Neurology 2018
112
11

Use of antihypertensives and the risk of Parkinson disease.
Claudia Becker, Susan S Jick, Christoph R Meier. Neurology 2008
163
10


Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
10

Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
Benjamin Wolozin, Stanley W Wang, Nien-Chen Li, Austin Lee, Todd A Lee, Lewis E Kazis. BMC Med 2007
270
10

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.
Göran Bertilsson, Cesare Patrone, Olof Zachrisson, Annica Andersson, Karin Dannaeus, Jessica Heidrich, Jarkko Kortesmaa, Alex Mercer, Elisabet Nielsen, Harriet Rönnholm,[...]. J Neurosci Res 2008
244
10

Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies.
Andrew O Koob, Kiren Ubhi, Johan F Paulsson, Jeffery Kelly, Edward Rockenstein, Michael Mante, Anthony Adame, Eliezer Masliah. Exp Neurol 2010
79
11

Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies.
Lin Lu, Deng-Lei Fu, Hui-Qin Li, Ai-Ju Liu, Ji-Huang Li, Guo-Qing Zheng. PLoS One 2014
73
12


Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Mark L Wahlqvist, Meei-Shyuan Lee, Chih-Cheng Hsu, Shao-Yuan Chuang, Jiunn-Tay Lee, Hsin-Ni Tsai. Parkinsonism Relat Disord 2012
149
10


Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease.
I Moroo, T Yamada, H Makino, I Tooyama, P L McGeer, E G McGeer, K Hirayama. Acta Neuropathol 1994
118
9

Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Iciar Aviles-Olmos, Patricia Limousin, Andrew Lees, Thomas Foltynie. Brain 2013
189
9

Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
S P Patil, P D Jain, P J Ghumatkar, R Tambe, S Sathaye. Neuroscience 2014
160
9

Dementia is associated with insulin resistance in patients with Parkinson's disease.
Domenico Bosco, Massimiliano Plastino, Dario Cristiano, Carmela Colica, Caterina Ermio, Matteo De Bartolo, Pasquale Mungari, Giulia Fonte, Domenico Consoli, Arturo Consoli,[...]. J Neurol Sci 2012
83
9

Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease.
Ingemar Björkhem, Anita Lövgren-Sandblom, Valerio Leoni, Steve Meaney, Lovisa Brodin, Lisette Salveson, Kristian Winge, Sven Pålhagen, Per Svenningsson. Neurosci Lett 2013
69
11

Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.
Guodong Liu, Nicholas W Sterling, Lan Kong, Mechelle M Lewis, Richard B Mailman, Honglei Chen, Douglas Leslie, Xuemei Huang. Mov Disord 2017
50
16

Increased risk of Parkinson disease with diabetes mellitus in a population-based study.
Yu-Wan Yang, Teng-Fu Hsieh, Chia-Ing Li, Chiu-Shong Liu, Wen-Yuan Lin, Jen-Huai Chiang, Tsai-Chung Li, Cheng-Chieh Lin. Medicine (Baltimore) 2017
62
12

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.